OriGene Technologies uses a high-throughput, genome-wide approach to develop products for drug development and cancer/disease-specific research. OriGene has a searchable bank of over 500,000 cDNA Clones, many of which are sequenced and expression-validated. In addition, we offer over 27,000 recombinant proteins and 144,000+ antibodies.